MDLN - CIK 0002046386
The table below shows Medline Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenue | $7.35B | $6.64B |
| Cost of revenue | $5.51B | $4.82B |
| Gross profit | $1.84B | $1.82B |
| R&D | - | - |
| SG&A | $1.23B | $1.07B |
| Operating income | $422.00M | $571.00M |
| Income tax | $52.00M | $16.00M |
| Net income | - | $319.00M |
| EPS (diluted) | $0.16 | - |
Medline Inc. reported annual revenue of $28.43B for fiscal year 2025. That is up 11.5% from $25.51B in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.